Ester Zamarrón de Lucas | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Dr. Ester Zamarrón de Lucas | AI in Healthcare | Best Researcher Award

Doctor at La Paz University Hospital, Spain

Dr. Ester Zamarrón de Lucas is a distinguished medical professional specializing in pulmonology, with extensive experience in clinical research, patient care, and academic contributions. She has dedicated her career to advancing respiratory medicine, particularly in the areas of obstructive lung diseases, sleep apnea, and critical care pulmonology. With a strong academic background and a commitment to evidence-based medicine, Dr. Zamarrón has actively participated in national and international research projects, contributing significantly to the understanding and treatment of respiratory diseases.

Profile

Scopus

Education

Dr. Zamarrón’s academic journey began with her undergraduate studies in Medicine and Surgery at the Universidad de Santiago de Compostela (2006-2012). She later pursued specialized training in pulmonology at the Hospital Universitario La Paz (2013-2017). Her commitment to continuous learning is evident through her multiple postgraduate qualifications, including master’s degrees in airway diseases, chronic obstructive pulmonary disease (COPD), and applied health statistics. In 2021, she earned her Doctorate in Medicine and Surgery with International Mention from the Universidad Autónoma de Madrid, receiving the highest honors for her research on the impact of CPAP therapy on diabetic nephropathy and obstructive sleep apnea.

Experience

Dr. Zamarrón has amassed significant clinical experience across various prestigious institutions. She served as a resident doctor in pulmonology at Hospital Universitario La Paz, followed by research and clinical roles in Madrid’s leading hospitals, including Hospital Universitario de Móstoles and Clínica Cemtro. Since 2017, she has been a specialist in pulmonology at Hospital Universitario La Paz, providing expert care in respiratory disorders. Additionally, she has contributed her expertise to the QuirónSalud group, further broadening her impact on patient care and medical research.

Research Interests

Dr. Zamarrón’s research focuses on a range of respiratory conditions, including COPD, sleep apnea, pulmonary hypertension, and critical care medicine. She has been actively involved in studies assessing the interplay between obstructive lung diseases and cardiovascular health, as well as the impact of novel therapeutic interventions on respiratory failure. Her work extends to environmental health, examining the effects of air pollution on pulmonary diseases and disease progression in conditions like idiopathic pulmonary fibrosis.

Awards and Recognitions

Dr. Zamarrón has been recognized for her contributions to respiratory medicine and clinical research. Her doctoral thesis received the “Premio Extraordinario de Doctorado” for its outstanding impact. She has also been the recipient of research grants from institutions such as the Instituto de Salud Carlos III, which supported her work on CPAP therapy in patients with comorbidities. Her expertise has been acknowledged through invitations to international conferences and collaborations with leading respiratory research networks, such as ERN-Lung Academy.

Selected Publications

Zamarrón E, Ribate D, Fernández-Lahera J, Villasante C. “Biological Treatments in Asthma: A New Era.” Rev Patol Respir. 2018;21:43-5.

Mediano O, Casitas R, Villasante C, et al. “Dynamic Hyperinflation in Asthmatic Patients with Exercise-Induced Bronchoconstriction.” Ann Allergy Asthma Immunol. 2017;118:427-32. (Cited by 50 articles)

Zamarrón-de Lucas E, García-Fernández E, Carpio C, et al. “Massive Cardiac Lipomatosis: An Autopsy Finding in Sudden Death.” Med Clin. 2016;146:541-3. (Cited by 30 articles)

Zamarrón E, Galera R, Falcone A, Martínez C. “Diagnostic and Therapeutic Protocol for Respiratory Failure in Emergency Care.” Medicine. 2018;12:3903-7. (Cited by 40 articles)

Zamarrón E, Carpio C, Santiago A, et al. “Impact of Non-Invasive Respiratory Therapies in Severe COVID-19 Patients.” An RANM. 2020;137:154-60. (Cited by 75 articles)

Díaz-García E, Jaureguizar A, Casitas R, et al. “SMAD4 Overexpression in Sleep Apnea Patients: A Potential Link to Cardiometabolic Comorbidities.” J Clin Med. 2020;9:2378. (Cited by 55 articles)

Zamarrón E, Jaureguizar A, García-Sánchez A, et al. “Obstructive Sleep Apnea and Impaired Renal Function in Diabetic Kidney Disease.” Sci Rep. 2021;11:5675. (Cited by 60 articles)

Conclusion

Dr. Ester Zamarrón de Lucas stands as a highly respected pulmonologist whose contributions to research, clinical care, and medical education continue to shape the field of respiratory medicine. Her expertise in sleep apnea, COPD, and pulmonary hypertension, coupled with her dedication to advancing treatment strategies, underscores her impact on patient health and scientific progress. Through her work, she remains committed to improving respiratory care and fostering innovative approaches to disease management.

Eliano Cascardi | Artificial intelligence in medicine | Inspirational Scientist Visionary Award

Posted on by sciencefather

Prof. Dr. Eliano Cascardi | Artificial intelligence in medicine | Inspirational Scientist Visionary Award

Pathologist MD, PhD | University of Bari Aldo Moro | Italy

Eliano Cascardi, MD, PhD, is a distinguished pathologist specializing in precision and regenerative medicine. He is currently affiliated with the Department of Precision and Regenerative Medicine and Ionian Area at the University of Bari “Aldo Moro,” Policlinico of Bari, Italy. His expertise extends to pathology, laboratory medicine, and translational research, with a focus on cancer diagnostics and innovative therapeutic approaches. Dr. Cascardi is a prolific contributor to scientific literature and an active participant in EU-funded research initiatives.

Profile

Scopus

Education

Dr. Cascardi has an impressive educational background. He earned his MD from the University of Bari “Aldo Moro,” where he developed an early focus on cancer pathology. He specialized in pathology at the same institution, completing an experimental thesis on the role of neutrophilic elastase in breast cancer vascular invasion. Furthering his academic pursuits, he obtained a PhD in Biomedical Sciences and Oncology from the University of Torino. Additionally, he achieved scientific qualification as an associate professor in the Italian higher education system, solidifying his academic credentials.

Experience

Dr. Cascardi has accumulated extensive experience as a pathologist and researcher. His clinical and academic endeavors are deeply rooted in precision medicine, emphasizing accurate cancer diagnostics and exploring novel therapeutic pathways. He has contributed significantly to the study of skin and female cancer pathology, including breast and gynecologic cancers. Beyond clinical practice, Dr. Cascardi has been a key investigator in multiple research projects, integrating his expertise into multidisciplinary efforts.

Research Interests

Dr. Cascardi’s research interests focus on skin and female cancer pathology, particularly breast and gynecologic cancers. His work aims to improve diagnostic accuracy for unknown primary cancers and develop targeted therapeutic strategies. His innovative studies include identifying tissue origins of cancers and exploring the roles of specific enzymes and biomarkers in tumor progression and treatment response.

Awards and Nominations

Dr. Cascardi has been recognized for his contributions to pathology and oncology through prestigious awards and nominations. His groundbreaking research and dedication to advancing precision medicine have earned him accolades in the scientific community. His involvement in EU-funded and national research projects underscores his reputation as a leader in his field.

Selected Publications

Dellino, M. et al. (2024). “Artificial Intelligence in Cervical Cancer Screening: Opportunities and Challenges.” AI, 5(4), 2984–3000. [Cited by 10 articles].

Cazzato, G., Cascardi, E., et al. (2024). “The Rarity in the Rarity: Presentation of Three Cases of Cutaneous Carcinosarcoma.” Dermatopathology, 11(3), 209. [Cited by 7 articles].

Cascardi, E., et al. (2024). “Oral–Gut–Estrobolome Axis May Exert a Selective Impact on Oral Cancer.” Journal of Dental Research. [Cited by 5 articles].

Forte, M., Cascardi, E., et al. (2024). “Gingival Cyst of the Adult: A Case Description with Literature Analysis.” Reports, 7(3), 51. [Cited by 2 articles].

Sallicandro, L., Cascardi, E., et al. (2024). “Increased Vasoactive Intestinal Peptide in Polycystic Ovary Syndrome Patients.” Frontiers in Endocrinology, 15. [Cited by 3 articles].

Dellino, M., Cascardi, E., et al. (2023). “The Strange Case of Twin Reversed Arterial Perfusion (TRAP) Sequence.” Diagnostics, 13, 3109. [Cited by 8 articles].

Cazzato, G., Cascardi, E., et al. (2023). “Cutaneous Metastasis from Internal Malignancies: The Revealing Role of the Skin.” Cancers, 15(17), 4351. [Cited by 6 articles].

Conclusion

Dr. Eliano Cascardi exemplifies excellence in precision and regenerative medicine. His impactful research, dedication to advancing cancer diagnostics, and contributions to medical education have established him as a leading figure in pathology and oncology. Through his clinical expertise and academic endeavors, he continues to influence the landscape of cancer research and treatment, driving innovation and improving patient care.